JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3601
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.89B
| $1.47M | ﹤0.01% |
9,492
+657
| +7% | +$103K |
2013 Q2
39 quarters
|
|
3602
Carvana
CVNA
$45.6B
| $1.47M | ﹤0.01% |
749,270
+464,960
| +164% | +$807K |
2017 Q2
23 quarters
|
|
|
CDMO
3603
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.47M | ﹤0.01% |
78,157
+8,065
| +12% | +$132K |
2015 Q1
32 quarters
|
|
3604
PUT
Danaher
DHR
$153B
| $1.46M | ﹤0.01% |
6,542
-149,122
| -96% | -$33.9M |
2021 Q2
7 quarters
|
|
|
ADAM
3605
Adamas Trust
ADAM
$671M
| $1.46M | ﹤0.01% |
146,065
+28,247
| +24% | +$306K |
2015 Q3
30 quarters
|
|
3606
Planet Labs
PL
$6.44B
| $1.45M | ﹤0.01% |
369,861
+174,122
| +89% | +$780K |
2021 Q4
5 quarters
|
|
3607
MacroGenics
MGNX
$228M
| $1.45M | ﹤0.01% |
202,342
-33,755
| -14% | -$203K |
2013 Q4
37 quarters
|
|
|
CLDL
3608
DELISTED
Direxion Daily Cloud Computing Bull 2X Shares
CLDL
| $1.45M | ﹤0.01% |
200,000
| – | – |
2021 Q1
8 quarters
|
|
3609
First Trust Enhanced Short Maturity ETF
FTSM
$6.62B
| $1.45M | ﹤0.01% |
24,354
-16,308
| -40% | -$971K |
2016 Q4
25 quarters
|
|
3610
Intapp
INTA
$2.91B
| $1.45M | ﹤0.01% |
32,263
-881
| -3% | -$31K |
2021 Q3
6 quarters
|
|
3611
Standard Motor Products
SMP
$827M
| $1.45M | ﹤0.01% |
39,243
+9,954
| +34% | +$379K |
2013 Q2
39 quarters
|
|
|
GHIX
3612
DELISTED
Gores Holdings IX, Inc. Class A Common Stock
GHIX
| $1.45M | ﹤0.01% |
+143,430
| New | +$1.43M |
2023 Q1
0 quarters
|
|
3613
Global X Silver Miners ETF NEW
SIL
$4.29B
| $1.45M | ﹤0.01% |
47,042
-3,489
| -7% | -$101K |
2018 Q2
19 quarters
|
|
|
RDFN
3614
DELISTED
Redfin
RDFN
| $1.44M | ﹤0.01% |
159,065
+46,468
| +41% | +$346K |
2017 Q3
22 quarters
|
|
|
WSR
3615
DELISTED
Whitestone REIT
WSR
| $1.44M | ﹤0.01% |
156,401
-17,068
| -10% | -$165K |
2017 Q3
22 quarters
|
|
3616
Deluxe
DLX
$1.03B
| $1.44M | ﹤0.01% |
90,007
+32,820
| +57% | +$598K |
2013 Q2
39 quarters
|
|
3617
CryoPort
CYRX
$875M
| $1.44M | ﹤0.01% |
59,911
+10,933
| +22% | +$238K |
2018 Q2
19 quarters
|
|
3618
Mirion Technologies
MIR
$4.06B
| $1.44M | ﹤0.01% |
168,242
+33,203
| +25% | +$263K |
2022 Q2
3 quarters
|
|
3619
CALL
PNC Financial Services
PNC
$86.7B
| $1.44M | ﹤0.01% |
11,300
-19,300
| -63% | -$2.91M |
2021 Q2
7 quarters
|
|
3620
PUT
Centene
CNC
$32.3B
| $1.44M | ﹤0.01% |
22,700
-14,600
| -39% | -$1.04M |
2022 Q3
2 quarters
|
|
|
ONG
3621
DELISTED
Direxion Daily Oil Services Bull 2X Shares
ONG
| $1.43M | ﹤0.01% |
49,092
-324
| -0.7% | -$12K |
2022 Q1
4 quarters
|
|
3622
BrightView Holdings
BV
$969M
| $1.43M | ﹤0.01% |
254,520
-12,688
| -5% | -$85.6K |
2018 Q2
19 quarters
|
|
3623
Ginkgo Bioworks
DNA
$788M
| $1.43M | ﹤0.01% |
26,885
-3,946
| -13% | -$250K |
2021 Q3
6 quarters
|
|
|
SQSP
3624
DELISTED
Squarespace, Inc.
SQSP
| $1.43M | ﹤0.01% |
44,925
-51,408
| -53% | -$1.27M |
2021 Q2
7 quarters
|
|
3625
CALL
DoorDash
DASH
$82.7B
| $1.42M | ﹤0.01% |
22,400
-16,000
| -42% | -$918K |
2021 Q4
5 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.